Central And South America Nutraceuticals Market growing at a CAGR of 8.4% from 2025 to 2033
The Central and South America nutraceuticals market size was estimated at USD 30.18 billion in 2024 and is projected to reach USD 62.17 billion by 2033, growing at a CAGR of 8.4% from 2025 to 2033. This market is primarily driven by the growing demand for natural and plant-based products, supportive government initiatives and regulatory frameworks, the rise in fitness culture and sports participation, and a growing middle-class population with increased purchasing power in the region.
Key Market Trends & Insights
- By product, the dietary supplements segment held the highest market share of 31.4% in 2024.
- Based on application, the weight management & satiety segment held the highest market share in 2024.
- By distribution channel, the offline segment held the highest market share in 2024.
Market Size & Forecast
- 2024 Market Size: USD 30.18 Billion
- 2033 Projected Market Size: USD 62.17 Billion
- CAGR (2025-2033): 8.4%
Request Free Sample Report: https://www.grandviewresearch.com/industry-analysis/csa-nutraceuticals-market-report/request/rs1
Consumers are increasingly looking for natural, organic, and plant-based nutraceutical options, driven by growing environmental awareness and concerns over synthetic ingredients. The rich biodiversity of Central and South America (CSA) supports the use of traditional botanical ingredients, which companies incorporate into innovative supplements.
The increased fitness culture and sports engagement across the region drives demand for sports nutrition supplements, such as protein powders, amino acids, and energy boosters. Younger age groups, particularly millennials and Gen Z, are embracing active lifestyles and demand products that improve performance and recovery. Fitness influencers and gym clubs are key channels for advertising these products, increasing adoption and awareness. This trend splits the nutraceutical market from broad wellness into specialized segments. Companies operating in the market are launching sports nutritional products enriched with vitamins and minerals, aligning with broader health and wellness trends.
Consumer Insights
The nutraceuticals market in CSA shows a clear divide between urban and rural consumers, shaped by differences in access, awareness, affordability, and product preferences. Urban areas in Brazil, Argentina, Colombia, and Chile are hubs for nutraceutical consumption, with consumers having better access to modern pharmacies, supermarkets, and e-commerce platforms. These urban buyers often prefer specialized products such as collagen powders, plant-based protein, and sleep aids, and are more receptive to international or premium brands.
Gender is a key factor in influencing nutraceutical consumption trends across CSA, with women being the main consumers and decision-makers. At the same time, men increasingly develop an interest in targeted applications such as sports nutrition and vitality supplements. Women comprise a larger proportion of the consumer base for nutraceuticals, especially in beauty-from-within, hormonal balance, weight management, and family well-being. They are more likely to investigate product benefits and are affected by peer opinions, influencer endorsements, and clean-label statements.
Product Insights
The dietary supplements segment dominated the market with a revenue share of 31.4% in 2024. The growing health consciousness has significantly heightened the demand for vitamins, minerals, and herbal supplements that promote immune function. Patients in CSA are actively taking supplements to avoid illness instead of seeking treatment after the fact. This change of attitude is also driven by wider exposure to health information through the internet. Government-led wellness campaigns and rising healthcare costs encourage consumers to invest in self-care.
CSA Nutraceuticals Market Report Scope
|
Report Attribute |
Details |
|
Market size value in 2025 |
USD 32.69 billion |
|
Revenue forecast in 2033 |
USD 62.17 billion |
|
Growth rate |
CAGR of 8.4% from 2025 to 2033 |
|
Actuals |
2021 – 2024 |
|
Forecast period |
2025 – 2033 |
|
Quantitative units |
Revenue in USD million and CAGR from 2025 to 2033 |
|
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, trends |
|
Segments covered |
Product, application, distribution channel |
|
Countries covered |
Brazil, Argentina |
|
Key companies profiled |
Amway Corp., BASF SE, Bayer AG, Glanbia Public Limited Company, GSK plc, Herbalife International of America, Inc., Nestlé Health Science S.A. |
|
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
|
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |